Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies.
暂无分享,去创建一个
E. Touboul | R. Labianca | P. Ruszniewski | P. Hammel | E. Deniaud-Alexandre | F. Selle | A. de Gramont | J. Balosso | T. André | C. Louvet | F. Huguet | P. Artru
[1] R. Wolff,et al. Neoadjuvant chemotherapy improves outcomes of chemoradiation therapy for locally advanced pancreatic cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] B. Chauffert,et al. Phase III trial comparing initial chemoradiotherapy (intermittent cisplatin and infusional 5-FU) followed by gemcitabine vs. gemcitabine alone in patients with locally advanced non metastatic pancreatic cancer: A FFCD-SFRO study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] A. Chang,et al. Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer. , 2005, International journal of radiation oncology, biology, physics.
[4] S. Lipsitz,et al. A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. , 2005, International journal of radiation oncology, biology, physics.
[5] L. Case,et al. Phase II Trial of Induction Gemcitabine/CPT-11 Followed by a Twice-Weekly Infusion of Gemcitabine and Concurrent External Beam Radiation for the Treatment of Locally Advanced Pancreatic Cancer , 2005, American journal of clinical oncology.
[6] R. Labianca,et al. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] M. Fernex. [The article by C. Hill and F. Doyon, The frequency of cancer in France in 2000 and trends after 1950, in Bulletin du Cancer 2005;92:7-11]. , 2005, Bulletin du cancer.
[8] C. Hill,et al. La fréquence des cancers en France en 2000 et son évolution depuis 1950 , 2005 .
[9] C. Hill,et al. [The frequency of cancer in France in year 2000, and trends since 1950]. , 2005, Bulletin du cancer.
[10] W. Miller,et al. Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] P. Hammel,et al. Phase II study of leucovorin, 5-fluorouracil and gemcitabine for locally advanced and metastatic pancreatic cancer (FOLFUGEM 2). , 2004, Gastroenterologie clinique et biologique.
[12] E. Van Cutsem,et al. Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] P. Philip,et al. Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] M. Dimopoulos,et al. Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] G. Hédelin,et al. Cancer incidence and mortality in France over the period 1978-2000. , 2003, Revue d'epidemiologie et de sante publique.
[16] A. Kuten,et al. Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer , 2002, Journal of surgical oncology.
[17] P. Hammel,et al. Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] R. Talamini,et al. Radiotherapy and continuous infusion 5-fluorouracil in patients with nonresectable pancreatic carcinoma. , 2001, International journal of radiation oncology, biology, physics.
[19] M. Reni,et al. Definitive results of a phase II trial of cisplatin, epirubicin, continuous-infusion fluorouracil, and gemcitabine in stage IV pancreatic adenocarcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] P. Ruszniewski,et al. Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM). , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] E. Touboul,et al. Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study. , 2000, International journal of radiation oncology, biology, physics.
[22] W. Scheithauer,et al. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin , 1999, British Journal of Cancer.
[23] I. Awad,et al. Protracted 5-Fluorouracil Infusion with Concurrent Radiotherapy as a Treatment for Locally Advanced Pancreatic Carcinoma , 2000 .
[24] J. Gligorov,et al. [Adenocarcinoma of the pancreas. General characteristics]. , 1998, Presse medicale.
[25] D. V. Von Hoff,et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] D. V. Von Hoff,et al. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.
[27] D. Neuberg,et al. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Birgir Gudjonsson,et al. Cancer of the pancreas: 50 years of surgery , 1987, Cancer.
[29] P. Engstrom,et al. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] J. Barkin,et al. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5‐fluorouracil), and high dose radiation + 5‐fluorouracil. The gastrointestinal tumor study group , 1981, Cancer.